By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
PreferencesDenyAccept
Privacy Preference Center
When you visit websites, they may store or retrieve data in your browser. This storage is often necessary for the basic functionality of the website. The storage may be used for marketing, analytics, and personalization of the site, such as storing your preferences. Privacy is important to us, so you have the option of disabling certain types of storage that may not be necessary for the basic functioning of the website. Blocking categories may impact your experience on the website.
Reject all cookiesAllow all cookies
Manage Consent Preferences by Category
Essential
Always Active
These items are required to enable basic website functionality.
Marketing
These items are used to deliver advertising that is more relevant to you and your interests. They may also be used to limit the number of times you see an advertisement and measure the effectiveness of advertising campaigns. Advertising networks usually place them with the website operator’s permission.
Personalization
These items allow the website to remember choices you make (such as your user name, language, or the region you are in) and provide enhanced, more personal features. For example, a website may provide you with local weather reports or traffic news by storing data about your current location.
Analytics
These items help the website operator understand how its website performs, how visitors interact with the site, and whether there may be technical issues. This storage type usually doesn’t collect information that identifies a visitor.
Save preferences
ProgramSpeakersSpeeddatesPartnersAboutUpdatesTickets

September 3, 2025

Exploring the Intersection of Biotechnology and Machine Learning at Cradle

The convergence of biotechnology and machine learning is creating new opportunities for innovation. Cradle, a forward-thinking company, exemplifies this trend by harnessing the potential of AI to address complex biological challenges.

This article delves into the insights shared by Elise de Reus, Co-Founder of Cradle, during a conversation at Upstream Festival.

Addressing ethical considerations

As with any emerging technology, ethical implications are at the forefront of discussions surrounding biotechnology. Elise emphasizes the importance of regulating the applications of technology rather than the technology itself. "You need to regulate the things that people build with the tool, not the tool itself," she states. 

Funding and growth strategy

Cradle's journey has included significant fundraising, raising approximately one hundred million. This funding is pivotal in proving core hypotheses and scaling operations. As Elise reflects, "The goal has always been to have sufficient capital to really prove the core hypotheses." The focus on long-term goals and thoughtful planning has shaped Cradle's growth trajectory.

The future of protein engineering

Cradle is poised to make a lasting impact on various industries, from pharmaceuticals to agriculture. By leveraging advanced machine learning techniques, the company is uncovering new possibilities in protein design and synthesis. The integration of biology and technology is not just an innovative approach; it is essential for tackling some of the world's most pressing challenges.

You can dive into the full recap of her session here.

And remember to pre-register for Upstream 2026 here.

All updates